Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1186/cc9311
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2011
- Urheber
- DOI
-
10.1186/cc9311
- URN
-
urn:nbn:de:101:1-2020072315094453805575
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sørensen, Benny
- Spahn, Donat R.
- Innerhofer, Petra
- Spannagl, Michael
- Rossaint, Rolf
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2011
Ähnliche Objekte (12)
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial
Clinical Use of Factor IX Concentrates
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial
Clinical Use of Factor IX Concentrates
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial
Clinical Use of Factor IX Concentrates